We use cookies to improve your browsing experience on our website.
Please visit our Privacy Notice for more information about cookies and how we use them. We recommend that you accept the use of cookies for better navigation.

Open Abdomen Management

 

About Open Abdomen Management

The open abdomen management technique is the intentional creation of an open abdomen, leaving the fascial edges of the abdomen unapproximated. This technique allows a damaged or edematous viscera to expand, reducing intra-abdominal pressure (IAP) and related complications, and can help achieve primary fascial closure as early as clinically feasible.1,2

Key features for a temporary abdominal closure to manage an open abdomen include2,3

  • Easily applied
  • Limit contamination
  • Decrease bowel edema
  • Protect the viscera, fascia, and skin
  • Fluid removal
  • Minimize fascial retraction and loss of domain
  • Facilitate primary fascial closure


Products described on this website (and associated product information), may not be available for sale in all markets as a result of local regulatory requirements. For information regarding product availability in your market, please contact your local Acelity/KCI representative here.

The Science Behind Our Products

Our solutions are built on a deep understanding of wound healing, supported by a large body of clinical evidence

Why It Matters

Clinical research has shown that removing potentially detrimental peritoneal fluid and achieving primary fascial closure are important goals when managing patients who require an open abdomen for the treatment of critical illness.4

The method of a temporary abdominal closure may play an important role in positive clinical and economic outcomes.5,6,7,8,9,10

In a twenty-center observational prospective study comparing ABTHERA™ Open Abdomen Negative Pressure Therapy (n=111) to Barker’s vacuum-packing technique (n=57) in trauma and surgical patients after 48-hours of consistent temporary abdominal closure therapy, ABTHERA™ Therapy was associated with a significantly improved 30-day primary fascial closure rate and a 30-day all-cause mortality rate (p=0.03 and 0.01, respectively). It was also associated with a reduction in length of stay.5

Clinician Resources

KCI offers ABTHERA™ Open Abdomen Negative Pressure Therapy for management of the open abdomen.

Clinical Evidences